(4-Pack) SERMORELIN – 10mg
nothing more. nothing less.
SHIPS IN 1 BUSINESS DAY
Lightning-fast shipping · USA · tracked
For research use only — not for human consumption, therapeutic, or diagnostic use. By adding to cart you acknowledge these terms.
Blank. Credentials
Institutional-grade credentials you can verify
About This Compound
Deep technical insights for clinical research
Primary Research Applications
This compound is supplied strictly for in-vitro and preclinical research use only. Research focuses on the modulation of cellular repair mechanisms and upregulation of specific growth factor receptors in laboratory models.
Evaluation of metabolic activity and proliferation rates in relevant cell lineages.
Investigation of intracellular signaling cascades in controlled laboratory settings.
Research Community Feedback
"Consistency is paramount in our cellular model testing. Blank's peptides have maintained the tightest purity specs of any RUO vendor we've audited."
Dr. Julian Kessler
Lead Investigator, Biomatrix Labs
"The availability of detailed MS and HPLC data on the product page saved us two days of redundant internal verification. Professional grade synthesis."
Anika S. Singh
Synthetics Quality Control
"Finally, a supplier that doesn't hide behind consumer marketing. Stark, clear, and high-purity. Exactly what a modern lab needs."
Prof. David Emmerich
Applied Peptide Research
Complete The Protocol
Pairs & Supplies
The compounds and tools researchers stack with (4-Pack) SERMORELIN - 10mg.
Peer-Reviewed Literature
Related Studies
Endocrine and Metabolic Effects of Long-Term Administration of Growth Hormone-Releasing Hormone-(1-29)-NH2 in Age-Advanced Men and Women
Journal of Clinical Endocrinology & Metabolism
5-month trial demonstrated significant increases in skin thickness and lean body mass in males receiving nightly subcutaneous sermorelin injections with improved wellbeing markers.
Sermorelin: A Better Approach to Management of Adult-Onset Growth Hormone Insufficiency?
Clinical Interventions in Aging
Comprehensive analysis proposing sermorelin as preferable to recombinant GH for growth hormone replacement, highlighting its advantage of maintaining physiological GH pulsatility.
Beyond the Androgen Receptor: The Role of Growth Hormone Secretagogues in the Modern Management of Body Composition
Translational Andrology and Urology
Review documenting GHS effects on lean mass, adiposity reduction, and potential adjunctive therapy for hypogonadism with comparable fat loss to recombinant GH therapy.
A Two-Year, Open-Label, Multi-Center Study to Evaluate the Safety and Efficacy of Sermorelin (Geref Diagnostic)
Growth Hormone & IGF Research
Two-year open-label study in GH-deficient children demonstrated sermorelin maintained sustained increases in growth velocity, height SDS, and IGF-I without clinically significant adverse events or antibody development.
The Effect of GHRH Analog on Body Composition and Metabolic Parameters in HIV Lipodystrophy
Clinical Endocrinology
GHRH analog therapy reduced trunk fat by 6.2%, increased lean body mass by 1.3 kg, and improved lipid profiles in HIV patients with lipodystrophy over 12 weeks versus placebo.
Growth Hormone Releasing Hormone (GHRH) Neurons and GHRH-Neuron Subtypes in the Hypothalamus
Frontiers in Neuroendocrinology
Comprehensive mapping of GHRH neuronal circuits in the hypothalamus explaining why GHRH analogs like sermorelin preserve physiological pulsatility while exogenous GH replacement suppresses it.